UPDATE: JPMorgan Upgrades Ultragenyx Pharma (RARE) to Overweight
Tweet Send to a Friend
(Updated - February 11, 2022 4:28 AM EST)
JPMorgan analyst Cory Kasimov upgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Cory Kasimov upgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
